# SenseTime Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sensetime-medical

- Industry: Healthcare IT
- Headquarters: Shanghai, China
- Total disclosed funding: $173M
- Latest round: Series B (Jul 26, 2026)
- Investors on record: 11

## About

Based in Shanghai, China and founded in 2022, Shanghai SenseTime Shancui Medical Technology Co., Ltd., trading under the name SenseTime Medical, operates as a provider of intelligence medical solution that focuses on the research and development of AI (Artificial Intelligence) diagnosis and treatment platform. The company operates under SenseTime Group Inc., an AI software company listed on Hong Kong Exchanges and Clearing (HKEX).

In July 2026, Shanghai SenseTime Shancui Medical Technology Co., Ltd. raised over USD 100 million in series B funding from NewMargin Ventures, Zhongdian Shurong Investment Management, Luenmei Group, and other investors.

SenseTime Medical's main products include medical large-scale language model intelligent agent platform, an AI imaging and surgical planning system, an AI pathology system, and multimodal model training infrastructure.

The company generates revenue by providing AI diagnosis and treatment platform and related solutions.

SenseTime Medical will use the series B funding to continuously strengthen the R&D and productization capabilities of medical world models, accelerate the global business layout, expand into new business areas such as medical embodied intelligence, and further consolidate its position in the field of global medical world model. The company is planning for its final round of financing before going public.

## Funding rounds

- Series B, Jul 26, 2026, $100M — NewMargin Ventures, Zhongdian Shurong Investment Management, Luenmei Group
- Series A, Apr 20, 2026, $73M — Huagai Capital, Lenovo Capital and Incubator Group, Lion Global Investors, Far East Horizon, Bridge Capital, Linchuang Capital, Hongfeng Venture, CAS Capital

## Investors

- Huagai Capital (https://capitalatlas.ai/funds/huagai-capital) — Series A
- Lenovo Capital and Incubator Group (https://capitalatlas.ai/funds/lenovo-capital-and-incubator-group) — Series A
- Lion Global Investors (https://capitalatlas.ai/funds/lion-global-investors) — Series A
- Far East Horizon — Series A
- Bridge Capital (https://capitalatlas.ai/funds/bridge-capital) — Series A
- Linchuang Capital (https://capitalatlas.ai/funds/linchuang-capital) — Series A
- Hongfeng Venture (https://capitalatlas.ai/funds/hongfeng-venture) — Series A
- CAS Capital — Series A
- NewMargin Ventures (https://capitalatlas.ai/funds/newmargin-ventures) — Series B
- Zhongdian Shurong Investment Management (https://capitalatlas.ai/funds/zhongdian-shurong-investment-management) — Series B
- Luenmei Group — Series B